article · Tropical Journal of Natural Product Research
Both Gossypium barbadense (GB) and Gossypium hirsitum (GH) are members of the Malvaceae family and the cotton genus. In order to reduce silver nitrate, aqueous extracts of both plants were used to synthesize biogenic silver nanoparticles (AgNPs) (AgNO3). The techniques employed to describe them included X-ray diffraction, ultraviolet-visible spectroscopy, scanning electron microscopy, energy dispersive X-ray (EDX), transmission electron microscopy (TEM), and the fourier transformed infrared (FTIR) spectrophotometer. The AgNPs were found to be crystalline according to the XRD spectra, but TEM images showed that they were evenly distributed, free of aggregation, and in irregular shapes with an average size of 21 nm. Only silver, oxygen, and carbon were present in the nanoparticles, according to the SEM and EDX data. Both AgNPs have excellent antimalarial efficacy when tested in vitro with Plasmodium falciparum, with IC50 values of 1.2 and 0.96 g/mL, weak antitrypanosomal potentials, and a good track record of negligible cytotoxicity against the HeLa cell line. Both AgNPs exhibit potent antiplasmodial and antibacterial characteristics, making them intriguing candidates for use in nanomedicines and other contexts where related applications are needed. The aim of this study is to biogenically synthesize silver nanoparticles (AgNPs) using the aqueous leaf extracts of GB and GH, analyze their ability to target the HeLa cell line, and determine whether they have antimalarial and antitrypanosomal properties.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.26538/tjnpr/v7i3.26
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.